sequencing)

4 trials

Sponsors

West China Hospital, Sichuan University, Shanghai Pulmonary Hospital, Beijing Chest Hospital, Capital Medical University, Beijing Chest Hospital Affiliated to Capital Medical University

Conditions

Lung CancerNSCLCNon-small cell lung cancernon-small cell lung cancer (NSCLC), colorectal cancer (CRC)

Early Phase 1

Utility of BDA-NGS for plasma-based molecular detection and guidance of treatment in patients with advanced NSCLC

Active, not recruitingChiCTR1900027046

Shanghai Pulmonary HospitalLung Cancer

Start: 2019-11-30Updated: 2019-11-04

Human EGFR/ALK Mutation Combo Detection Kit (Hybrid Capture-Based Next Generation Sequencing)

Active, not recruitingChiCTR2000039940

Beijing Chest Hospital Affiliated to Capital Medical UniversityNon-small cell lung cancer

Start: 2019-04-17Updated: 2021-02-22

Unknown Phase

Multi-gene mutation detection kit for human lung cancer (Hybridization capture sequencing) clinical trial

RecruitingChiCTR1800019838

West China Hospital, Sichuan UniversityNSCLC

Start: 2018-12-01Updated: 2018-12-04

Clinical trials verifying the consistency of AmoyDx Essential NGS Panel (Reversible Terminator Sequencing) with local tests

RecruitingChiCTR2000039738

Beijing Chest Hospital, Capital Medical Universitynon-small cell lung cancer (NSCLC), colorectal cancer (CRC)

Start: 2020-12-20Updated: 2021-02-16